Inhibition of platelet aggregation by a new stable prostacyclin introduced in therapy of patients with progressive scleroderma.
Keller
J
J
Kaltenecker
A
A
Schricker
K T
KT
Neidhardt
B
B
Hornstein
O P
OP
D000328:Adult; D000368:Aged; D011464:Epoprostenol / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016285:Iloprost; D008297:Male; D008875:Middle Aged; D008947:Mixed Connective Tissue Disease / Q000097:blood / Q000188:drug therapy; D010974:Platelet Aggregation / Q000187:drug effects*; D012595:Scleroderma, Systemic / Q000097:blood / Q000188:drug therapy*
D011464:Epoprostenol; D016285:Iloprost